Intervention in early HIV infection.
1. The primary goals of early intervention in HIV infection are to prevent or delay disease progression and to interrupt HIV transmission. 2. After assessing the stage of a patient's infection, the next goal of early intervention is to minimize the risk of progression. The initial assessment of an HIV-infected individual should include a comprehensive evaluation of all previous disease exposures that might become problematic with immune system compromise. 3. Two antiviral agents are licensed to treat HIV infection: zidovudine and didanosine. Only zidovudine is approved for treatment of early HIV infection and is recommended for all HIV-positive adults with or without symptoms of disease progression who have absolute CD4 helper cell counts less than 500.